Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
for
Angina, Heart Disease
Location: Beverly Hills CA
Sponsor: Westside Medical Associates of Los Angeles
Sex: All
Age: 18+
Code: NCT01804543
Recruiting
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
for
Tricuspid Valve Regurgitation
Location: Los Angeles CA, Thousand Oaks CA, Plano TX, Atlanta GA,
Sponsor: inQB8 Medical Technologies, LLC
Sex: All
Age: 18+
Code: NCT06611579
Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Duarte CA, La Jolla CA, San Diego CA, Stanford CA,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Glendale CA, Sacramento CA, Albuquerque NM, El Paso TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase 3, Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Fullerton CA, Irvine CA, Los Angeles CA, Pomona CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pain and Major Depressive Disorder
for
Major Depressive Disorder, Chronic Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT04556890
Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
for
Propionic Acidemia
Location: Los Angeles CA, Stanford CA, Houston TX, Edmonton,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT04159103
Phase 1, Phase 2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Orange CA, Irvine CA, Los Angeles CA, Fresno CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Location: Orange CA, Los Angeles CA, Salem OR, Portland OR,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT04256317
Phase 2, Phase 3, Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
for
Lymphatic Malformations
Location: Orange CA, Palo Alto CA, Oakland CA, Portland OR,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT05948943
Phase 2, Phase 3, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Orange CA, Irvine CA, Duarte CA, Encinitas CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
for
Cancer Pain, Visceral Pain, Gastrointestinal Neoplasms,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04907643
Recruiting
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Location: Orange CA, Irvine CA, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687123
Phase 1, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Orange CA, Irvine CA, Salt Lake City UT, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for
Dravet Syndrome
Location: Orange CA, Salt Lake City UT, Seattle WA, Vancouver,